682 related articles for article (PubMed ID: 25080504)
1. LRRK2 delays degradative receptor trafficking by impeding late endosomal budding through decreasing Rab7 activity.
Gómez-Suaga P; Rivero-Ríos P; Fdez E; Blanca Ramírez M; Ferrer I; Aiastui A; López De Munain A; Hilfiker S
Hum Mol Genet; 2014 Dec; 23(25):6779-96. PubMed ID: 25080504
[TBL] [Abstract][Full Text] [Related]
2. The G2019S variant of leucine-rich repeat kinase 2 (LRRK2) alters endolysosomal trafficking by impairing the function of the GTPase RAB8A.
Rivero-Ríos P; Romo-Lozano M; Madero-Pérez J; Thomas AP; Biosa A; Greggio E; Hilfiker S
J Biol Chem; 2019 Mar; 294(13):4738-4758. PubMed ID: 30709905
[TBL] [Abstract][Full Text] [Related]
3. Alterations in late endocytic trafficking related to the pathobiology of LRRK2-linked Parkinson's disease.
Rivero-Ríos P; Gómez-Suaga P; Fernández B; Madero-Pérez J; Schwab AJ; Ebert AD; Hilfiker S
Biochem Soc Trans; 2015 Jun; 43(3):390-5. PubMed ID: 26009181
[TBL] [Abstract][Full Text] [Related]
4. LRRK2 transport is regulated by its novel interacting partner Rab32.
Waschbüsch D; Michels H; Strassheim S; Ossendorf E; Kessler D; Gloeckner CJ; Barnekow A
PLoS One; 2014; 9(10):e111632. PubMed ID: 25360523
[TBL] [Abstract][Full Text] [Related]
5. LRRK1 phosphorylation of Rab7 at S72 links trafficking of EGFR-containing endosomes to its effector RILP.
Hanafusa H; Yagi T; Ikeda H; Hisamoto N; Nishioka T; Kaibuchi K; Shirakabe K; Matsumoto K
J Cell Sci; 2019 Jun; 132(11):. PubMed ID: 31085713
[TBL] [Abstract][Full Text] [Related]
6. Distinct Roles for RAB10 and RAB29 in Pathogenic LRRK2-Mediated Endolysosomal Trafficking Alterations.
Rivero-Ríos P; Romo-Lozano M; Fernández B; Fdez E; Hilfiker S
Cells; 2020 Jul; 9(7):. PubMed ID: 32709066
[TBL] [Abstract][Full Text] [Related]
7. The Upshot of LRRK2 Inhibition to Parkinson's Disease Paradigm.
Esteves AR; G-Fernandes M; Santos D; Januário C; Cardoso SM
Mol Neurobiol; 2015 Dec; 52(3):1804-1820. PubMed ID: 25394383
[TBL] [Abstract][Full Text] [Related]
8. An early endosome regulator, Rab5b, is an LRRK2 kinase substrate.
Yun HJ; Kim H; Ga I; Oh H; Ho DH; Kim J; Seo H; Son I; Seol W
J Biochem; 2015 Jun; 157(6):485-95. PubMed ID: 25605758
[TBL] [Abstract][Full Text] [Related]
9. Novel insights into the neurobiology underlying LRRK2-linked Parkinson's disease.
Gómez-Suaga P; Fdez E; Fernández B; Martínez-Salvador M; Blanca Ramírez M; Madero-Pérez J; Rivero-Ríos P; Fuentes JM; Hilfiker S
Neuropharmacology; 2014 Oct; 85():45-56. PubMed ID: 24863040
[TBL] [Abstract][Full Text] [Related]
10. Leucine-rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity that is altered in familial Parkinson's disease R1441C/G mutants.
Li X; Tan YC; Poulose S; Olanow CW; Huang XY; Yue Z
J Neurochem; 2007 Oct; 103(1):238-47. PubMed ID: 17623048
[TBL] [Abstract][Full Text] [Related]
11. Roles of the Drosophila LRRK2 homolog in Rab7-dependent lysosomal positioning.
Dodson MW; Zhang T; Jiang C; Chen S; Guo M
Hum Mol Genet; 2012 Mar; 21(6):1350-63. PubMed ID: 22171073
[TBL] [Abstract][Full Text] [Related]
12. Adenoviral-mediated expression of G2019S LRRK2 induces striatal pathology in a kinase-dependent manner in a rat model of Parkinson's disease.
Tsika E; Nguyen AP; Dusonchet J; Colin P; Schneider BL; Moore DJ
Neurobiol Dis; 2015 May; 77():49-61. PubMed ID: 25731749
[TBL] [Abstract][Full Text] [Related]
13. LRRK2 and Rab GTPases.
Pfeffer SR
Biochem Soc Trans; 2018 Dec; 46(6):1707-1712. PubMed ID: 30467121
[TBL] [Abstract][Full Text] [Related]
14. Cellular effects mediated by pathogenic LRRK2: homing in on Rab-mediated processes.
Madero-Pérez J; Fdez E; Fernández B; Lara Ordóñez AJ; Blanca Ramírez M; Romo Lozano M; Rivero-Ríos P; Hilfiker S
Biochem Soc Trans; 2017 Feb; 45(1):147-154. PubMed ID: 28202668
[TBL] [Abstract][Full Text] [Related]
15. Late endosomal traffic of the epidermal growth factor receptor ensures spatial and temporal fidelity of mitogen-activated protein kinase signaling.
Taub N; Teis D; Ebner HL; Hess MW; Huber LA
Mol Biol Cell; 2007 Dec; 18(12):4698-710. PubMed ID: 17881733
[TBL] [Abstract][Full Text] [Related]
16. LRRK2 and Parkinson's Disease: From Lack of Structure to Gain of Function.
Blanca Ramírez M; Madero-Perez J; Rivero-Rios P; Martinez-Salvador M; Lara Ordonez AJ; Fernandez B; Fdez E; Hilfiker S
Curr Protein Pept Sci; 2017; 18(7):677-686. PubMed ID: 26965688
[TBL] [Abstract][Full Text] [Related]
17. Rab4 affects both recycling and degradative endosomal trafficking.
McCaffrey MW; Bielli A; Cantalupo G; Mora S; Roberti V; Santillo M; Drummond F; Bucci C
FEBS Lett; 2001 Apr; 495(1-2):21-30. PubMed ID: 11322941
[TBL] [Abstract][Full Text] [Related]
18. LRRK2 and RAB7L1 coordinately regulate axonal morphology and lysosome integrity in diverse cellular contexts.
Kuwahara T; Inoue K; D'Agati VD; Fujimoto T; Eguchi T; Saha S; Wolozin B; Iwatsubo T; Abeliovich A
Sci Rep; 2016 Jul; 6():29945. PubMed ID: 27424887
[TBL] [Abstract][Full Text] [Related]
19. The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human.
Mir R; Tonelli F; Lis P; Macartney T; Polinski NK; Martinez TN; Chou MY; Howden AJM; König T; Hotzy C; Milenkovic I; Brücke T; Zimprich A; Sammler E; Alessi DR
Biochem J; 2018 Jun; 475(11):1861-1883. PubMed ID: 29743203
[TBL] [Abstract][Full Text] [Related]
20. LRRK2 in Parkinson's disease: protein domains and functional insights.
Mata IF; Wedemeyer WJ; Farrer MJ; Taylor JP; Gallo KA
Trends Neurosci; 2006 May; 29(5):286-93. PubMed ID: 16616379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
